Gilead Sciences (GILD) Non-Current Debt (2010 - 2026)
Gilead Sciences (GILD) reported Non-Current Debt of $23.83 billion for Q2 2026, up 7.6% from $22.14 billion a year earlier and up 14.2% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Non-Current Debt (2010 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences posted Non-Current Debt of $22.13 billion, down 11.1% from FY2024.
- Non-Current Debt has a five-year compound annual growth rate of -5.0% (FY2020 to FY2025).
- By year, Non-Current Debt came in at $24.9 billion in FY2024 (+7.4%), $23.19 billion in FY2023 (+1.0%), $22.96 billion in FY2022 (-8.8%) and $25.18 billion in FY2021 (-12.1%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Debt since Q4 2024.
- Year over year, Non-Current Debt gained in five of the last eight quarters, with an average decline of 0.1%.
- The high point for year-over-year Non-Current Debt in five years was Q2 2026 (growth of 7.6%); the low point was Q2 2023 (a decline of 15.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $20.86 billion (Q1 2026), $22.13 billion (Q4 2025) and $22.14 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 42.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.83 Bn |
| Mar 31, 2026 | 20.86 Bn |
| Dec 31, 2025 | 22.13 Bn |
| Sep 30, 2025 | 22.14 Bn |
| Jun 30, 2025 | 22.14 Bn |
| Mar 31, 2025 | 22.15 Bn |
| Dec 31, 2024 | 24.90 Bn |
| Sep 30, 2024 | 21.44 Bn |
| Jun 30, 2024 | 21.54 Bn |
| Mar 31, 2024 | 21.53 Bn |
| Dec 31, 2023 | 23.19 Bn |
| Sep 30, 2023 | 23.19 Bn |
| Jun 30, 2023 | 21.21 Bn |
| Mar 31, 2023 | 22.96 Bn |
| Dec 31, 2022 | 22.96 Bn |
| Sep 30, 2022 | 22.95 Bn |
| Jun 30, 2022 | 25.20 Bn |
| Mar 31, 2022 | 25.18 Bn |
| Dec 31, 2021 | 25.18 Bn |
| Sep 30, 2021 | 25.18 Bn |
API Access
Gilead Sciences Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();